SenzaGen AB (OSTO:SENZA) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SENZA SenzaGen AB OSTO:SENZA
72 GF Score
Price kr5.30
GF Value kr6.41
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is SenzaGen AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

SenzaGen AB Valuation Rank Related Terms

OSTO:SENZA
72GF Score
SenzaGen AB OSTO:SENZA
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SenzaGen AB (OSTO:SENZA) Overvalued in 2026?

Based on GuruFocus' analysis, SenzaGen AB stock appears to be undervalued. The current stock price of kr5.30 is trading 17.3% below its estimated GF Value™ of kr6.41. GuruFocus considers SenzaGen AB to be Modestly Undervalued.

Key valuation signals for OSTO:SENZA:

  • Valuation Rank:
  • GF Value™: kr6.41 vs. price of kr5.30 (17.3% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the OSTO:SENZA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SenzaGen AB Business Description

Address Scheelevagen 8, Medicon Village, Building 401, Lund, SWE, 223 63
SenzaGen AB markets, sells, and performs in vitro testing using its Genomic Allergen Rapid Detection (GARD) platform through its laboratory and a network of contract research organizations. The company provides animal-free testing solutions for chemical compounds used in industries such as cosmetics, chemicals, pharmaceuticals, medical devices, and food and nutrition. Geographically, it operates in the Americas, EMEA, and APAC, with the majority of revenue from EMEA.
72GF Score

Get the complete analysis for OSTO:SENZA

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.30
Price
kr6.41
GF Value